Botanical species · safety record

Guaiacum officinale

The EFSA Compendium of Botanicals holds 12 constituent measurements for Guaiacum officinale. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Guaiacum officinale L.

12Constituent measurements
0Safety records
8Cited sources
12Licensed products (Canada)

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 12 licensed products naming Guaiacum officinale as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Extract types on licence

  • Dry

Source material stated

  • Resin
  • Resin powder
  • Stem resin
  • Wood

What the records describe

Constituents measured

  • Guaiacin2
  • Pentacyclic triterpene saponins2
  • Saponins2
  • (-)-guaiaretic acid1
  • Alpha-guaiaconic acid1
  • Isoguaiacin1
  • Lignans1
  • Meso-dihydroguaiaretic acid1
  • Triterpene saponins1

Plant parts

  • Wood6
  • Bark2
  • Fruit unspecified2
  • Flower1
  • Leaves1

Preparations

  • Solvent extraction12

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

SubstancePlant partPreparationConcentrationAnalytical methodSource
GuaiacinLeavesSolvent extraction—Nuclear Magnetic Resonance (NMR)Resolve DOI
Pentacyclic triterpene saponinsBarkSolvent extraction—Standard Chromatographic tests (paper- thin layer- and column chromatography)Resolve DOI
SaponinsFruit unspecifiedSolvent extraction—HPLC with standard detection methodsResolve DOI
SaponinsFlowerSolvent extraction—High Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)Resolve DOI
(-)-guaiaretic acidWoodSolvent extraction—Standard Chromatographic tests (paper- thin layer- and column chromatography)No resolvable identifier
Alpha-guaiaconic acidWoodSolvent extraction—Standard Chromatographic tests (paper- thin layer- and column chromatography)No resolvable identifier
GuaiacinWoodSolvent extraction—Standard Chromatographic tests (paper- thin layer- and column chromatography)No resolvable identifier
IsoguaiacinWoodSolvent extraction—Standard Chromatographic tests (paper- thin layer- and column chromatography)No resolvable identifier
LignansWoodSolvent extraction—HPLC with standard detection methodsNo resolvable identifier
Meso-dihydroguaiaretic acidWoodSolvent extraction—Standard Chromatographic tests (paper- thin layer- and column chromatography)No resolvable identifier
Pentacyclic triterpene saponinsFruit unspecifiedSolvent extraction—Nuclear Magnetic Resonance (NMR)No resolvable identifier
Triterpene saponinsBarkSolvent extraction—Nuclear Magnetic Resonance (NMR)No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

  1. AHMAD, VU., UDDIN, S., BANO, S., FATIMA, I. 2 SAPONINS FROM FRUITS OF GUAIACUM-OFFICINALE. Phytochemistry, 1989, vol. 28, no. 8, p. 2169-2171. DOI
  2. Chavez, Kathryn J., Feng, Xiaohong., Flanders, James A., Rodriguez, Eloy., Schroeder, Frank C. Spirocyclic Lignans from Guaiacum (Zygophyllaceae) Induce Apoptosis in Human Breast Cancer Cell Lines. Journal of natural products, 2011, vol. 74, no. 5, p. 1293-1297.
  3. Saba, Nikhat., Ahmad, Viqar Uddin., Ali, Zulfiqar., Khan, Khalid Mohammed. Separation and identification of anew saponin from the flowers of Guaiacum officinale L. . Natural product research, 2010, vol. 24, no. 20, p. 1877-1882. DOI
  4. Saba, Nikhat., Khatoon, Rasheeda., Ali, Zulfiqar., Ahmad, Viqar Uddin. A New Bidesmoside Saponin from the Bark of Guaiacum officinale. Journal of the chemical society of pakistan, 2012, vol. 34, no. 2, p. 448-450.
  5. Alves, TMD., Nagem, TJ., Ribeiro, A., Mendes, NM., Gomez, JD., Zani, CL., Hamburger, M., Hostettmann, K. Molluscicidal saponins from Guaiacum officinale (Zygophyllaceae). International journal of pharmacognosy, 1996, vol. 34, no. 2, p. 81-86.
  6. Ahmad, V U., Perveen, S., Bano, S. Guaiacin A and B from the Leaves of Guaiacum officinale.. Planta medica, 1989, vol. 55, no. 3, p. 307-8. DOI
  7. AHMAD, VU., BANO, N., BANO, S. SAPOGENINS FROM GUAIACUM-OFFICINALE. Phytochemistry, 1984, vol. 23, no. 11, p. 2613-2616. DOI
  8. King, F.E., Wilson, J.G. The chemistry of extractives from hardwoods. Part XXXVI. The lignans of guaiacum officinale L. Journal of the chemical society (resumed), 1964, p. 4008-4011.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue